Articles tagged with #pharmaceuticals
Latest articles tagged with #pharmaceuticals, sorted from newest to oldest.

Eli Lilly Ceo Says Medicare Coverage of Obesity Drugs Could 'change the Game' for Upcoming Pill Launch
The pharmaceutical industry has been abuzz with excitement over the upcoming launch of Eli Lilly's new obesity drug, and the company's CEO has just given a major reason for the optimism. In a recent interview with CNBC, David Ricks, the CEO of Eli Lilly, expressed his confidence that Medicare covera...

Trump Struck Deals with 16 Drug Companies. but They're Still Raising Prices This Year
Trump's Promise to Lower Drug Prices Falls Short President Trump's administration made headlines in 2019 when it announced a deal with 16 major pharmaceutical companies to lower the prices of certain prescription medications. However, a recent report by NPR revealed that despite these deals, the com...

Wegovy Obesity Pill Now Available at Pharmacies : Shots
The US Food and Drug Administration (FDA) has given the green light for the sale of Wegovy, an injectable medication that has been shown to lead to significant weight loss in adults with obesity. The pill, which is administered once a week, is now available at pharmacies across the country, marking ...

Fda Approves First Glp-1 Pill for Obesity from Wegovy Maker Novo Nordisk
For years, people struggling with obesity have been looking for effective and convenient ways to manage their weight. The pharmaceutical industry has been working tirelessly to develop new treatments that can safely and efficiently help individuals achieve a healthier weight. Recently, the US FDA ha...
Atorvastatin Recall May Affect Hundreds of Thousands of Patients – and Reflects Fda’s Troubles Inspecting Medicines Manufactured Overseas
Atorvastatin Recall Sparks FDA Concerns The US Food and Drug Administration (FDA) is facing increased scrutiny after a recent recall of the popular cholesterol-lowering medication Atorvastatin, which may affect hundreds of thousands of patients. The recall reflects the FDA's struggles with inspectin...